Early dynamics of a neutrophil interferon program drive immunotherapy resistance and limit durable anti-tumor immunity
Yang Gao, Emmanuel Anning, Linhua Wang…·Xiang H.-F. Zhang
This study identifies an early neutrophil interferon program that predicts resistance to anti-PD1 therapy and limits durable anti-tumor immunity.